0001104659-21-098427.txt : 20210730 0001104659-21-098427.hdr.sgml : 20210730 20210730202110 ACCESSION NUMBER: 0001104659-21-098427 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210728 FILED AS OF DATE: 20210730 DATE AS OF CHANGE: 20210730 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rowland Charles A Jr CENTRAL INDEX KEY: 0001383292 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37558 FILM NUMBER: 211134247 MAIL ADDRESS: STREET 1: 3338 LANCASHIRE RD CITY: FURLONG STATE: PA ZIP: 18925 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics plc CENTRAL INDEX KEY: 0001641640 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 56 FITZWILLIAM SQUARE CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: (610) 816-6640 MAIL ADDRESS: STREET 1: 1000 CONTINENTAL DRIVE STREET 2: SUITE 600 CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 FORMER COMPANY: FORMER CONFORMED NAME: Nabriva Therapeutics AG DATE OF NAME CHANGE: 20150507 4 1 tm2123737-6_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-07-28 0 0001641640 Nabriva Therapeutics plc NBRV 0001383292 Rowland Charles A Jr 414 COMMERCE DRIVE SUITE 120 FORT WASHINGTON PA 19034 1 0 0 0 Ordinary Shares 2021-07-28 4 A 0 17500 0 A 24550 D Share Options 1.08 2021-07-28 4 A 0 35000 0 A 2031-07-28 Ordinary Shares 35000 35000 D The reported transaction involved the reporting person's receipt of a grant of 17,500 restricted stock units. The total reported in Column 5 includes the 17,500 newly awarded restricted stock units. The number of ordinary shares reported on this Form 4 reflects a 1-for-10 reverse stock split effected on December 3, 2020. The option was granted on July 28, 2021. One hundred percent (100%) of the option will vest on July 31, 2022, subject to the reporting person's continued service on the board of directors of Nabriva Therapeutics plc. /s/ Robert Crotty, by power of attorney 2021-07-30